Xi-An Fu (X-A Fu)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 4

Top Topics

Radiation Induced

Endothelial Cells

Top Venues

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

This page only lists publications with an associated author ORCID identifier.

Publications

Tao Xie, Yu-Hao Ding, Chun-Sheng Sang, Ze-Xi Lin, Jun Dong, Xi-An Fu
Vitexin enhances radiosensitivity of mouse subcutaneous xenograft glioma by affecting the miR-17-5p/miR-130b-3p/PTEN/HIF-1α pathway. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 200 (6) (2024)
Tao Xie, Yu-Hao Ding, Chun-Sheng Sang, Ze-Xi Lin, Jun Dong, Xi-An Fu
Vitexin enhances radiosensitivity of mouse subcutaneous xenograft glioma by affecting the miR-17-5p/miR-130b-3p/PTEN/HIF-1α pathway. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 200 (6) (2024)
Tao Xie, Yu-Hao Ding, Chun-Sheng Sang, Ze-Xi Lin, Jun Dong, Xi-An Fu
Vitexin enhances radiosensitivity of mouse subcutaneous xenograft glioma by affecting the miR-17-5p/miR-130b-3p/PTEN/HIF-1α pathway. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2024)
T Xie, J-R Wang, C-G Dai, Xi-An Fu, J Dong, Q Huang
Vitexin, an inhibitor of hypoxia-inducible factor-1α, enhances the radiotherapy sensitization of hyperbaric oxygen on glioma. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 22 (7) (2019)